Apyx Medical Corp Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Apyx Medical Corp (APYX) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $2.10 million for the 1-month period ending 2023-01-31, per its 10-Q filed 2024-11-08.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2024-11-08
- Apyx Medical Corp unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2022-09-30 was $54.00K, a 3.85% increase year-over-year.
- Apyx Medical Corp unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2022-06-30 was $53.00K, a 3.92% increase year-over-year.
- Apyx Medical Corp unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2022-03-31 was $53.00K, a 10.42% increase year-over-year.
- Apyx Medical Corp unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-09-30 was $52.00K, a 20.93% increase year-over-year.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 1 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month as first filed | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month as first filed | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month |
|---|---|---|---|---|---|---|
| 2023-01-31 | $2.10M 10-Q · filed 2024-11-08 | |||||
| 2022-09-30 | $54.00K 10-Q · filed 2022-11-10 | $107.00K derived: sum of 2 quarters · filed 2022-11-10 | $160.00K 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $53.00K 10-Q · filed 2022-08-11 | $105.00K 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $53.00K 10-Q · filed 2022-05-12 | |||||
| 2021-09-30 | $52.00K 10-Q · filed 2022-11-10 | $103.00K derived: sum of 2 quarters · filed 2022-11-10 | $152.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $51.00K 10-Q · filed 2022-08-11 | $99.00K 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | $48.00K 10-Q · filed 2022-05-12 | |||||
| 2020-09-30 | $43.00K 10-Q · filed 2021-11-12 | $86.00K derived: sum of 2 quarters · filed 2021-11-12 | $125.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $43.00K 10-Q · filed 2021-08-12 | $86.00K 10-Q · filed 2021-08-12 | $82.00K 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $43.00K 10-Q · filed 2021-05-12 | $39.00K 10-Q · filed 2020-05-11 | ||||
| 2019-09-30 | $146.00K 10-Q · filed 2019-11-15 | $197.00K 10-Q · filed 2019-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |